Predict your next investment

Corporation
BUSINESS PRODUCTS & SERVICES | Packaging
tskg-hd.com

See what CB Insights has to offer

Investments

7

Partners & Customers

1

About Toyo Seikan Group Holdings

Toyo Seikan Group Holdings (TYO: 5901) engages in the manufacture and sale of packaging containers using metal, plastic, glass, and paper as the raw materials; and the contract manufacture and sale of aerosol products and general filling products. It is also involved in the manufacture and sale of steel plate and processed products.

Toyo Seikan Group Holdings Headquarter Location

1-3-1 uchisaiwaicho Chiyoda-ku

100-8522,

Japan

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Toyo Seikan Group Holdings Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Toyo Seikan Group Holdings Rank

Latest Toyo Seikan Group Holdings News

Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials of CLS001 for Corneal Endothelial Cell Regenerative Therapy

Jan 7, 2022

January 06, 2022 07:00 PM Eastern Standard Time TOKYO--( BUSINESS WIRE )-- Cellusion Inc. , a regenerative medicine startup aiming to solve the global Corneal transplant waiting list problem with a unique differentiation induction method from iPS cells to Corneal Endothelial Cell Substitute from iPS Cells (CECSi Cells) for bullous keratopathy novel treatment (PJ code: CLS001), today announced it has completed a 1.1 billion yen fundraising round led by existing investors DBJ Capital, Keio Innovation Initiative, and SMBC Venture Capital and new investors Gemseki, Toho Holding, Toyo Seikan Group Holdings and University of Tokyo Edge Capital Partners. The new round brings Cellusion’s total funding in the past year to 1.7 billion yen. [Use of the Funding] Cellusion will use the funding to prepare for the company-sponsored phase 1/2 clinical trials of CLS001 in Japan and overseas, enlarge both of its Tokyo-based research and business teams, and proceed with R&D activities of other pipelines. In addition, by promoting business cooperation with Toho Holdings, Japan-based pharmaceutical wholesaler, and Toyo Seikan Group Holdings, a Japanese multinational conglomerate packaging materials manufacturer, to build the supply chain of CLS001. Cellusion will enhance its efforts to deliver CLS001 for bullous keratopathy patients all over the world. [About CLS001] In spite of the fact that more than 13 million waiting patients for potential blinding diseases such as Bullous Keratopathy, which can only be prevented by corneal transplantation, only about 180,000 corneal transplants are performed annually worldwide. The reason for such a large medical supply-demand gap generated is because current treatments require donor corneas, skilled corneal transplant ophthalmologists, and Eye Banks. Cellusion is developing CLS001, CECSi cells for Corneal Endothelial regeneration to cure Bullous Keratopathy which is applied more than half of all cases of corneal transplantation. CLS001 is expected to replace the current supply limitations by combining “CECSi Cells made from iPS cells with excellent proliferative properties” and "a simple injection cell delivery procedure without needs of human expertise.“ The initiation approval of the CLS001 first in human investigator-initiated clinical study has already been obtained from the Keio University Specially Certified Committee for Regenerative Medicine as well as the Health Sciences Council of MHLW, the Ministry of Health, Labor and Welfare of Japan in July 2021. Keio University and Cellusion are scheduled to start the study at Keio University Hospital as soon as it is ready. [About Cellusion Inc.] Cellusion is a regenerative medicine startup born from the Department of Ophthalmology, Keio University School of Medicine in 2015. Cellusion aims to contribute to the improvement of health and well-being around the world by solving unmet medical needs in medicine with its cutting-edge cell therapy technologies, including a unique differentiation induction method from iPS cells to CECSi Cells. Cellusion’s mission is to a community the clear vision of the future with cellular technology breakthrough. Company: Cellusion Inc.

Toyo Seikan Group Holdings Investments

7 Investments

Toyo Seikan Group Holdings has made 7 investments. Their latest investment was in DAIZ as part of their Series B - III on February 2, 2022.

CBI Logo

Toyo Seikan Group Holdings Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/1/2022

Series B - III

DAIZ

$26.14M

Yes

2

1/25/2022

Seed

Subscribe to see more

$99M

Subscribe to see more

10

1/6/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

7/21/2021

Bridge - II

Subscribe to see more

Subscribe to see more

10

3/1/2021

Corporate Minority

Subscribe to see more

Subscribe to see more

10

Date

2/1/2022

1/25/2022

1/6/2022

7/21/2021

3/1/2021

Round

Series B - III

Seed

Series B

Bridge - II

Corporate Minority

Company

DAIZ

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$26.14M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

10

10

Toyo Seikan Group Holdings Acquisitions

1 Acquisition

Toyo Seikan Group Holdings acquired 1 company. Their latest acquisition was Stolle Machinery on October 04, 2011.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/4/2011

$99M

Acquired

1

Date

10/4/2011

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

1

Toyo Seikan Group Holdings Partners & Customers

1 Partners and customers

Toyo Seikan Group Holdings has 1 strategic partners and customers. Toyo Seikan Group Holdings recently partnered with Toyobo, Suntory Beverage & Food, Rengo, J&T Recycling, Asahi Group Holdings, Iwatani, Dai Nippon Printing, Toppan Printing, Fuji Seal, Hokkai Can Co., and Yoshino Kogyosho on June 6, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

6/30/2020

Partner

Japan

Suntory Launches New Joint Venture Company to Develop Innovative Anellotech Plas-TCat Plastics Recycling Technology.

Suntory Holdings Ltd. began collaborating with Anellotech , a US-based sustainable technology company , in 2012 .

1

Date

6/30/2020

Type

Partner

Business Partner

Country

Japan

News Snippet

Suntory Launches New Joint Venture Company to Develop Innovative Anellotech Plas-TCat Plastics Recycling Technology.

Suntory Holdings Ltd. began collaborating with Anellotech , a US-based sustainable technology company , in 2012 .

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.